Distinct effects of calorie restriction on adipose tissue cytokine and angiogenesis profiles in obese and lean mice

Nutrition & Metabolism

Eero Mervaala¹  Piet Finckenberg¹  Essi Martonen¹  Jin Shi¹  Eveliina Kurki¹ 

[1] Institute of Biomedicine, Pharmacology, Biomedicum Helsinki, University of Helsinki, P.O.Box 63, FI-00014, Helsinki, Finland

关键词: calorie restriction;    angiogenesis;    cytokines;    adipose tissue;   

Others  :  1131806
DOI  :  10.1186/1743-7075-9-64

 received in 2012-02-20, accepted in 2012-06-11,  发布年份 2012

【 摘 要 】

Background

Obesity associates with low-grade inflammation and adipose tissue remodeling. Using sensitive high-throughput protein arrays we here investigated adipose tissue cytokine and angiogenesis-related protein profiles from obese and lean mice, and in particular, the influence of calorie restriction (CR).

Methods

Tissue samples from visceral fat were harvested from obese mice fed with a high-fat diet (60% of energy), lean controls receiving low-fat control diet as well as from obese and lean mice kept under CR (energy intake 70% of ad libitum intake) for 50 days. Protein profiles were analyzed using mouse cytokine and angiogenesis protein array kits.

Results

In obese and lean mice, CR was associated with 11.3% and 15.6% reductions in body weight, as well as with 4.0% and 4.6% reductions in body fat percentage, respectively. Obesity induced adipose tissue cytokine expressions, the most highly upregulated cytokines being IL-1ra, IL-2, IL-16, MCP-1, MIG, RANTES, C5a, sICAM-1 and TIMP-1. CR increased sICAM-1 and TIMP-1 expression both in obese and lean mice. Overall, CR showed distinct effects on cytokine expressions; in obese mice CR largely decreased but in lean mice increased adipose tissue cytokine expressions. Obesity was also associated with increased expressions of angiogenesis-related proteins, in particular, angiogenin, endoglin, endostatin, endothelin-1, IGFBP-3, leptin, MMP-3, PAI-1, TIMP-4, CXCL16, platelet factor 4, DPPIV and coagulation factor III. CR increased endoglin, endostatin and platelet factor 4 expressions, and decreased IGFBP-3, NOV, MMP-9, CXCL16 and osteopontin expressions both in obese and lean mice. Interestingly, in obese mice, CR decreased leptin and TIMP-4 expressions, whereas in lean mice their expressions were increased. CR decreased MMP-3 and PAI-1 only in obese mice, whereas CR decreased FGF acidic, FGF basic and coagulation factor III, and increased angiogenin and DPPIV expression only in lean mice.

Conclusions

CR exerts distinct effects on adipocyte cytokine and angiogenesis profiles in obese and lean mice. Our study also underscores the importance of angiogenesis-related proteins and cytokines in adipose tissue remodeling and development of obesity.

【 授权许可】

   
2012 Kurki et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 2.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Kopelman PG: Obesity as a medical problem. Nature 2000, 404:635-643.
• [2]Bays HE, Gonzàlez-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB, Rodbard HW, Henry RR: Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther 2008, 6:343-368.
• [3]Rosen ED, Spiegelman BM: Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006, 444:847-853.
• [4]Ouchi N, Parker JL, Lugus JJ, Walsh K: Adipokines in inflammation and metabolic diseases. Nat Rev Immunol 2011, 11:85-97.
• [5]Suganami T, Ogawa Y: Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol 2010, 88:33-39.
• [6]Hajer GR, van Haeften TW, Visseran FLJ: Adipose tissue dysfunction in obesity, diabetes and vascular diseases. Eur Heart J 2008, 29:2959-2971.
• [7]Christiaens V, Lijnen HR: Angiogenesis and development of adipose tissue. Mol Cell Endocrinol 2010, 318:2-9.
• [8]Daquinag AC, Zhang Y, Kolonin MG: Vascular targeting of adipose tissue as an anti-obesity approach. Trends Pharmacol Sci 2011, 32:300-307.
• [9]Sun K, Kusminski CM, Scherer PE: Adipose tissue remodelling and obesity. J Clin Invest 2011, 6:2094-2101.
• [10]Montesano R, Mouron P, Orci L: Vascular outgrowths from tissue explants embedded in fibrin or collagen gels: a simple in vitro model of angiogenesis. Cell Biol Int Rep 1985, 9:869-875.
• [11]Varzaneh FE, Shillabeer G, Wong KL, Lau DC: Extracellular matrix components secreted by microvascular endothelial cells stimulate preadipocyte differentiation in vitro. Metabolism 1994, 43:906-912.
• [12]Silverman KJ, Lund DP, Zetter BR, Lainey LL, Shahood JA, Freiman DG, Folkman J, Barger AC: Angiogenic activity of adipose tissue. Biochem Biophys Res Commun 1988, 153:347-352.
• [13]Cao Y: Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat Rev Drug Discov 2010, 9:107-115.
• [14]Rupnick MA, Panigraphy D, Zhang C-Y, Dallabrida SM, Lowell BB, Langer R, Folkman MJ: Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A 2002, 99:10730-10735.
• [15]Bråkenhielm E, Cao R, Gao B, Angelin B, Cannon B, Parini P, Cao Y: Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ Res 2004, 94:1579-1588.
• [16]Fontana L, Klein S: Aging, adiposity, and calorie restriction. JAMA 2007, 297:986-994.
• [17]Papakonstantinou E, Flatt WP, Huth PJ, Harris TB: High dietary calcium reduces body fat content, digestibility of fat, and serum vitamin D in rats. Obes Res 2003, 11:387-394.
• [18]Pilvi TK, Harala S, Korpela R, Mervaala EM: Effects of high calcium diet with different whey proteins on weight loss and weight re-gain in high-fat fed C57Bl/6 J mice. Br J Nutr 2009, 102:337-341.
• [19]Van Hinsbergh VWM, Engelse MA, Quax PH: Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol 2006, 26:716-728.
• [20]Fenton JI, Nunez NP, Perkins SN, Hord NG, Hursting SD: Diet-induced adiposity alters the serum profile of inflammation in C57BL/6 N mice as measured by antibody array. Diabetes Obes Metab 2009, 11:343-354.
• [21]Wang Q, Perrard XD, Perrard JL, Mansoori A, Raya JL, Hoogeveen R, Smith CW, Ballantyne CM, Wu H: Differential effect of weight loss with low-fat diet or high-fat diet restriction on inflammation in the liver and adipose tissue of mice with diet-induced obesity. Atherosclerosis 2011, 219:100-108.
• [22]Spencer M, Unal R, Zhu B, Rasouli N, McGehee RE, Peterson CA, Kern PA: Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance. J Clin Endocrinol Metab 2011, 96:E1990-E1998.
• [23]Sierra-Honigmann MR, Nath AK, Murakami C, García-Cardeña G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, Flores-Riveros JR: Biological action of leptin as an angiogenic factor. Science 1998, 281:1683-1686.
• [24]Suganami E, Takagi H, Ohashi J, Suzuma K, Suzuma I, Oh H, Watanabe D, Ojima T, Suganami T, Fujio Y, Nakao K, Ogawa Y, Yoshimura N: Leptin stimulates ischemia-induced retinal neovasculazation: possible role of vascular endothelial growth factor expressed in retinal endothelial cells. Diabetes 2004, 53:2443-2448.
• [25]Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y: Leptin induces vascular permeability and synenergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A 2001, 98:6390-6395.
• [26]O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JT, Olsen BR, Folkman J: Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277-285.
• [27]Silha JV, Krsek M, Sucharda P, Murphy LJ: Angiogenic factors are elevated in overweight and obese individuals. Int J Obes 2005, 29:1308-1314.
• [28]Lòpez-Novoa JM, Bernabeu C: The physiological role of endoglin in the cardiovascular system. Am J Physiol Heart Circ Physiol 2010, 299:H959-H974.
• [29]Chou YC, Perng JC, Juan CC, Jang SY, Kwok CF, Chen WL, Fong JC, Ho LT: Endothelin-1 inhibits insulin-stimulated glucose uptake in isolated rat adipocytes. Biochem Biophys Res Commun 1994, 202:688-693.
• [30]Lee YC, Juan CC, Fang VS, Hsu YP, Lin SH, Kwok CF, Ho LT: Evidence that endothelin-1 (ET-1) inhibits insulin-stimulated glucose uptake in rat adipocytes mainly through ETA receptors. Metabolism 1998, 47:1468-1471.
• [31]Juan CC, Chang CL, Lai YH, Ho LT: Endothelin-1 induces lipolysis in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2005, 288:E1146-E1152.
• [32]Juan CC, Chang LW, Huang SW, Chang CL, Lee CY, Chien Y, Hsu YP, Ho PH, Chen YC, Ho LT: Effect of endothelin-1 on lipolysis in rat adipocytes. Obesity 2006, 14:398-404.
• [33]van Harmelen V, Eriksson A, Åström G, Wåhlen K, Näslund E, Karpe F, Frayn K, Olsson T, Andersson J, Rydèn M, Arner P: Vascular peptide endothelin-1 links fat accumulation with alterations of visceral adipocyte lipolysis. Diabetes 2008, 57:378-386.
• [34]Eriksson AKS, van Harmelen V, Stenson BM, Åström G, Wåhle K, Laurencikiene J, Rydèn M: Endothelin-1 stimulated human adipocytes lipolysis through the ETA receptor. Int J Obes 2009, 33:67-74.
• [35]Ferri C, Bellini C, Desideri G, Baldoncini R, Properzi G, Santucci A, De Mattia G: Circulating endothelin-1 levels in obese patients with the metabolic syndrome. Exp Clin Endocrinol Diabetes 1997, 105:38-40.
• [36]Lijnen HR: Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost 2005, 3:35-45.
• [37]Morange PE, Lijnen HR, Alessi MC, Kopp F, Collen D, Juhan-Vague I: Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity. Arterioscler Thromb Vasc Biol 2000, 20:1150-1154.
• [38]Lijnen HR: Effect of plasminogen activator inhibitor-1 deficiency on nutritionally-induced obesity in mice. Thromb Haemost 2005, 93:816-819.
• [39]Ma LF, Mao SL, Taylor KL, Kanjanabuch T, Guan Y, Zhang Y, Brown NJ, Swift LL, McGuinness OP, Wasserman DH, Vaughan DE, Fogo AB: Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor-1. Diabetes 2004, 53:336-346.
• [40]Crandall DL, Quinet EM, Ayachi SE, Hreha AL, Leik CE, Savio DA, Juhan-Vague I, Alessi M-C: Modulation of adipose tissue development by pharmacological inhibition of PAI-1. Arterioscler Thromb Vasc Biol 2006, 26:2209-2215.
• [41]Lignen HR, Alessi MC, Frederix L, Collen D, Juhan-Vague I: Tiplaxtinin impairs nutritionally induced obesity in mice. Thromb Haemost 2006, 96:731-737.
• [42]Maquoi E, Munaut C, Colige A, Collen D, Lijnen HR: Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 2002, 51:1093-1101.
• [43]Maquoi E, Demeulemeester D, Voros G, Collen D, Lijnen HR: Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene activation. Thromb Haemost 2003, 89:696-704.
• [44]Lijnen HR, Maqui E, Hansen LB, Van Hoef B, Frederix L, Collen D: Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler Thromb Vasc Biol 2002, 22:374-379.
• [45]Chavey C, Mari B, Monthouel MN, Bonnafous S, Anglard P, Van Obberghen E, Tartare-Deckert S: Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 2003, 278:11888-11896.
• [46]Demeulemeester D, Collen D, Lijnen HR: Effect of matrix metalloproteinase inhibition on adipose tissue development. Biochem Biophys Res Commun 2005, 329:105-110.
• [47]Lijnen HR, Demeulemeester D, Van Hoef B, Collen D, Maquoi E: Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice. Thromb Haemost 2003, 89:249-255.
• [48]Nomiyama T, Perez-Tilve D, Ogawa D, Gizard F, Zhao Y, Heywood EB, Jones KL, Kawamori R, Cassis LA, Tschop MH, Bruemmer D: Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 2007, 117:2877-2888.
• [49]Kiefer FW, Zeyda M, Collinger K, Pfau B, Neuhofer A, Weichhart T, Säemann MD, Geyeregger R, Schlederer M, Kenner L, Stulnig TM: Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. Diabetes 2010, 59:935-946.
• [50]Gomez-Ambrosi J, Catalan V, Ramirez B, Rodriguez A, Colina I, Silva C, Roteller F, Mugueta C, Gil MJ, Cienfuegos JA, Salvador J, Fruhbeck G: Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab 2007, 92:3719-3727.
• [51]Kiefer FW, Zeyda M, Todoric J, Huber J, Geyeregger R, Weichhart T, Aszmann O, Ludvik B, Silberhumer GR, Prager G, Stulnig TM: Osteopontin expression in human and murine obesity: extensive local upregulation in adipose tissue by minimal systemic alterations. Endocrinology 2008, 149:1350-1357.
• [52]Deng L, Chen N, Li Y, Zheng H, Lei Q: CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer. Biochim Biophys Acta 2010, 1806:42-49.
• [53]Chen G, Lin S-C, Chen J, He L, Dong F, Xu J, Han S, Du J, Entman ML, Wang Y: CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis. J Am Soc Nephrol 2011, 22:1876-1886.
• [54]Sun Y, Chang Z, Zhang S: Increased serum CXCL16 level is a marker for acute coronary syndromes. Arctic Med Res 2008, 39:332-337.